##
|President:||The Lord Mayor of|Bristol|
|---|---|---|---|
|Officers||||
|Chair||Mrs 0 Grogono||
|General Secretary||Mrs EPritchard||
|Treasurer||Mrs CM Owen||
|Trustees||Mr SBlake||
|||Mrs A Carlton||
|||Mr GJ Clemente||
|||Mrs L Densham||
|||Mrs G Crease||
|||Dr G Crichton||
|||Mrs N Day||
|||Mrs0Grogono||
|||Mrs J Lockwood||
|||MrS Moorlen||
|||Mrs P Murphy||
|||Mrs CM Owen||
|||Mrs SSims||
|||Mrs AThomas||
|Advisors||||
|Bankers||National
Westminster|Bank pic|
|||Bristol City Oflice||
|Auditors||Elliott Bunker Limited||
|||1st Floor 61 Macrae|Road|
|||Ham Green||
|||Bristol||
|||BS20ODD||
|Stock brokers||Alpha Portfolio Management||
|||1 The Square||
|||Temple Quay||
|||Bristol||
|Registered|Office|Bristol Haematology|and Oncology Centre|
|||Horfield Road||
|||Bristol||
|Telephone||01173423432||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|YEAR ElfDED 31 DECE|MBER 202|2||||||
|---|---|---|---|---|---|---|---|
||||2022|||2021||
|||Unrestricted|Restricted|Total|IJnrestrtctsd|Restricted|Total|
||Note|fund|funds||fund|funds||
||||6|6|8|6|6|
|Income and endowments||||||||
|from||||||||
|Donations
and legacies||136,299|29,258|165,557|56,024|61,915|117,939|
|Other trading
activities||37,066||37,066|1,892||1,892|
|Investment
income||98,027|62|98,089|105,650|2|105,652|
|Total||271,392|29,320|300,712|163,566|61,917|225,483|
|Expenditure
on||||||||
|Raising funds||17,997||17,997|1,275||1,275|
|Chantable
activities||90,914|61,792|152,706|82,180|71,186|153,366|
|Total||108,911|61,792|170,703|83,455|71,186|154,641|
|Net income||162,481|(32,472)|130,009|80,111|(9,269)|70,842|
|Transfers||||||||
|Gross transfers
between|funds|(32,246)|32,246||(11,937)|11,937||
|Net income before other||||||||
|recognised
gains and||||||||
|losses||130,235|(226)|130,009|68,174|2,668|70,842|
|OTHER RECOGNISED GAINS||||||||
|(Losses)/gains
on investments||||||||
|Realised
gains on disposals||220,678||220,678|149,361||149,361|
|Unrsalised
gains/(losses)|on|||||||
|revaluations||(594,246)||(594,246)|337,019||337,019|
|Net movemsnt
In funds||(243,333)|(226)|(243,559)|554,554|2,668|557,222|
|Total funds brought forward||5,297,729|50,357|5,348,086|4,743,175|47,689|4,790,864|
|Total funds carried forward||5,054,396|50,131|5,104,527|5,297,729|50.357|5,348,086|
##
|YEAR ENDED 31 DECEM|B|ER 20|22|||||||
|---|---|---|---|---|---|---|---|---|---|
||||||||Total Funds||Total Funds|
||||||Note||2022||2021|
||||||||2|||
|Net cash generated
by operating|||activities||15||997||(38,684)|
|Cash from investing
activities||||||||||
|Interest end dividends||||||98,089||105,652||
|Transfer from stockbroker||||||25,728||(309,340)||
|Cash provided
by investing||activities|||||123,817||(203,688)|
|Change in cash and cash|equivalents|||in the year|||124,814||(242,372)|
|Cash and cash equivalents|brought||forward||||547,191||789.563|
|Cash and cash equivalents||carried forward|||||672,005||547,191|
##
##
##
##
##
##
##
##
##
|DonaNons|and legacies|||||||
|---|---|---|---|---|---|---|---|
||||2022|||2021||
|||Unrestricted|Restricted||Unrestricted|Restricted||
|||fund|fund|Total|fund|fund|Total|
||||6|8|6|6|6|
|Donations||71,475|29,258|100,733|15,282|61,915|77,197|
|Tax refunds||4,855||4,855||||
|Legacies||59,969||59,969|40,742||40,742|
|||136,299|29,258|165,557|56,024|61,915|117,939|
|Other activities to generate funds||||||||
||||2022|||2021||
|||Unrestricted|Restricted||Unrestricted|Restricted||
|||fund|fund|Total|fund|fund|Total|
|||6|6|6|f|6|f|
|Sale of merchandise||1,471||1,471|1,892||1,892|
|Evenls run|by the trust|35,595||35,595||||
|||37,066||37,066|1,892||1,892|
|Investment|income|||||||
||||2022|||2021||
|||Unrestricted|Restricted||Unrestricted|Restricted||
|||fund|fund|Total|fund|fund|Total|
|||6|6|f|6|6|6|
|Dividends|from UK listed|||||||
|investments||96,889||96,889|105,526||105,526|
|Interest receivable||1,138|62|1,200|124||126|
|||98,027||98,089|105,650|2|105,652|
|Raising Funds||||||||
||||2022|||2021||
|||Unrestricted|Restricted||Unrestricted|Restricted||
|||fund
6|fundf|Total
6|fund
8|fund
6|Total
6|
|Purchase ofitems for sale||837||837|1,275||1,275|
|Cost ofevents run by the Trust||17,160||17,160||||
|||17997,||17,997|1,275||1,275|
##
##
##
|Details ofCharffable Activities||||||||||
|---|---|---|---|---|---|---|---|---|---|
||||2022||||2021|||
||Unrestricted||Restricted|||Unrestricted|Restricted|||
||fund||fund||Total|fund|fund||Total|
||||6||6|6|6||6|
|Grants and DonaSons||||||||||
|Equipment
purchased|||45,610||45,610||63,689||63,689|
|Research salaries||14,072|||14,072|13,245|||13,245|
|Patient therapy||12,255|||12,255|786|||786|
|Patient amenities||10,847|4,532||15,379|11,509|7,497||19,006|
|Patient grants|||11,650||11,650|||||
|Courses training and library||11,973|||11,973|3,538|||3,538|
|Support costs||||||||||
|Insurance||1,053|||1,053|1,018|||1,018|
|Emoluments
ofemployee||9,131|||9,131|18,676|||18,676|
|Stockbroker's fess||25,569|||25,569|27,646|||27,646|
|Office cost||1,744|||1,744|1,337|||1,337|
|Governance costs||||||||||
|Auditor's
remuneration||4,270|||4,270|4,425|||4,425|
|||90,914|61,792||152,706|82,18D|T1186|,|153.MS|
|Staffcosts||||||||||
|Staff costs were as follows:||||||||||
||||||||2022||2021|
||||||||8||6|
|Charge for salaries from University|Hospitals|Bristol NHS|Foundation|Trust|||9,131||18,676|
##
##
|Fixed asset Investments||||
|---|---|---|---|
|||2022|2021|
|||8|8|
|Listed investments
at market||||
|value||||
|Fixed interest securities||730,847|616,340|
|Equity shares||3,210,276|2,294,011|
|Investment
trusts and unit trusts||269,977|1,699,206|
|||4,211,100|4,609,557|
|Cash||200,602|201,441|
|||4,411,702|4,810,998|
|Historical cost oflisted investments||4,088,267|3,892,473|
||Listed|||
||Investments|Cash|Total|
||8|8|8|
|Market value:||||
|At 31 December 2021|4,609,557|201,441|4,810,998|
|Additions|1,004,680|1,029,568|2,034,248|
|Disposals|(808,891)|(1,004,680)|(1,813,571)|
|Decrease In value
in year|(594,246)||(594,246)|
|Transfer to income||(25,727)|(25,727)|
|At 31 December 2022|4,211,100|200,602|4,411,702|
##
##
##
|12.|Funds||||||||
|---|---|---|---|---|---|---|---|---|
|||||At 31|||Transfers|At 31|
|||||December|Incoming|Resources|between|December|
|||||2021|resources|expended|funds|2022|
|||||||6||6|
||Restricted|Funds|||||||
||Equipment|fund - to purchase|snd maintain||||||
||medical equipment||||16,051|45,610|32,246|2,687|
||Research|Fund- to fund research projects||22,062|59|||22,121|
||Marsden bequest- to fund research salaries|||1,464|3|||1,467|
||Earmarked|fund- gifts for other|purposes|26,831|13,207|16,182||23,856|
|||||50,357|29,320|61,792|32,246|50,131|
||Unrestricted
funds||||||||
||General fund|||5,297,729|271,392|482,479|(32,246)|5,054,396|
|||||5,348,086|300,712|544,271||5,104,527|
|13.|Analysis ofnet assets between funds||||||||
|13.|Analysis ofnet assets betw|een funds|||||||
|---|---|---|---|---|---|---|---|---|
|||||||Unrestrtcted|Restricted|Total Funds|
|||||||Funds|Funds|2022|
|||||||f|||
||Investments|||||4,411,702||4,411,702|
||Current assets|||||651,874|50,131|702,005|
||Creditors due within one year|||||(9,180)||(9,180)|
|||||||5,054,396|50,131|5,104,527|
|14.|Approved
hrture funding||||||||
||At 31 December 2022 the trust had entered||into the following|funding|commitments.|||f|
||Courses for hospital staff|||||||16,000|
||Information
support
and research salaries|||||||23,500|
||Chemotherapy
treatment
chairs|||||||12,000|
||Radiation dose checking software|||||||6,998|
||Blood gas analyser|||||||30,150|
||Radiotherapy
planning
trial|||||||8,500|
||Fatigue app development|||||||4,586|
||TYA complimentary
therapies|||||||52,000|
||Patient support videos|||||||4,650|
||Practitioner for CART cell therapy|||||||167,000|
||Immobilisation
boards|||||||12,500|
||Decorating cancer support quiet room and||dinical trials room|||||8,500|
||Pilot ECG tip system|||||||5,500|
||Surface guided radiotherapy|system||||||750,000|
||Scalp cooling equipment|||||||28,200|
||Radiotherapy
kitchen|||||||26,000|
|Reconclllagon
of|net movement|in funds to cash flow from operating
act|ivities||
|---|---|---|---|---|
||||2022|2621|
|||||6|
|Net movement
in funds|||(243,559)|557,222|
|Less investment
income|||(98,089)|(105,652)|
|Less loss/gains
on|investments||373,568|(486,380)|
|Decrease/(increase)|in debtors||(28,985)|(1,015)|
|(Decrease)/increase|in creditors||(1,938)|(2,859)|
|Net cash generated|by operating|activities|997|(38,884)|